Regional registry of patient alloantibodies: First-year experience

Transfusion

Volumn 50, Issue 7, 2010, Pages 1465-1470

  Schwickerath, Vicki ^a   Kowalski, Mary ^a   Menitove, Jay E ^a  

^a Division of New York Blood Center Enterprises   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; DISEASE REGISTRY; HOSPITAL SERVICE; HUMAN; IMMUNOASSAY; INTERNET; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY;

BLOOD TRANSFUSION; COSTS AND COST ANALYSIS; HEMOLYSIS; HUMANS; ISOANTIBODIES; REGISTRIES;

EID: 77954322330     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02629.x     Document Type: Article

References (13)

1. Heddle NM, Soutar RL, O'Hoski PL, Singer J, McBride JA, Ali MA. A retrospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haemat 1995 91 : 1000 5.
2. Pineda AA, Vamvakas EC, Gordon LD, Winters GL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999 39 : 1097 103.
3. Combs MR, Arney RS, Telen MJ. Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang 2006 91 : 353 68.
4. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000 40 : 1127 31.
5. Tormey LA, Stack G. The persistence and evidence of blood groups alloantibodies in men. Transfusion 2009 49 : 505 12.
6. Schonewille H, van de Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006 46 : 250 6.
7. Vaccines, Blood, and Biologics, FDA. Fatalities reported to FDA following blood collection and transfusion: Annual summary for fiscal year 2008 cited 2009 Aug]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/BloodSafety/ucm113649.htm
8. SHOT Writing Group. Annual report 2008. p. 101 12 cited 2009 Sept]. Available from: URL: http://www.shotuk.org
9. Powers A, Chandrashekhar S, Mohammed M, Uhl L. Identification and evaluation of false-negative antibody screens. Transfusion 2010 50 : 617 21.
10. Knowles SM, Milkins CE, Chapman JF, Scott M. The United Kingdom National External Quality Assessment Scheme (blood transfusion laboratory practice): trends in proficiency and practice between 1985 and 2000. Transfus Med 2002 23 : 11 23.
11. Robillard P, Brottet E, Karl Itaj N. Positive impact of online inter-hospital consultation of transfusion history on incidence of red cell ABO mistransfusions, acute and delayed hemolytic transfusion reactions. Transfusion 2006 46 : 13A 14A.
12. Engelfreit CP, Reesink HW. Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang 2006 91 : 353 4.
13. MacIvor D, Triulzi DJ, Yazer MH. Enhanced detection of blood bank sample collection errors with a centralized patient database. Transfusion 2009 49 : 40 3.